Senior insider sale
Group VP & Rilonacept GM at KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC — senior position signals high conviction
$115.0K
2.37K shares
What this filing means
MOAT ROSS plans to sell 2.37K shares of KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC valued at approximately $115.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/6/2026ACC: 0001921094-26-000368
Officer· Group VP & Rilonacept GM
Since Apr 2021
2.37K
Shares to sell
$115.0K
Approx. market value
2.37K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Lapse
Equity Compensation
4/1/2026
2.37KTotal acquired2.37K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/1/2026 | Restricted Stock Lapse Equity Compensation | 2.37K | — |
| Total | 2.37K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.37K
Market value
$115.0K
4/6/2026
Total
Units
2.37K
Value
$115.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/6/2026 | 2.37K | $115.0K | NASDAQ | Planned |
| Total | 2.37K | $115.0K | ||